AMG generated over $1 billion of EBITDA, up 33% year over year, and record economic earnings per share of $18.28, representing annual growth of 37%.
Within private markets, our Affiliates manage $120 billion in assets under management across roughly 30 global and regional private equity, credit, direct lending, real estate, infrastructure, and private market solution strategies, offering investors diversification, income, and inflation protection across market cycles.
We have established three new partnerships in this segment over the last 24 months, in Comvest, OCP Asia, and Abacus, and have invested in distribution and product development at Pantheon, PFM, and Baring Asia to continue to address growing demand for both institutional and wealth investors globally.
Collectively, our Affiliates have raised nearly $25 billion in the private markets over the course of 2021, generating organic growth north of 20%, and each have significant dry power -- powder to capitalize on market opportunities ahead.
Dedicated ESG strategies across our Affiliates now account for over $90 billion of our assets under management, a segment that is growing organically at a double-digit rate.
Our Affiliates in these areas generate approximately $35 billion in net client flows, which accelerated in the second half of the year, and we will continue to invest in these attractive areas.
And so far in 2022, we've made a significant incremental investment in Systematica, which together will contribute approximately $120 million in annual EBITDA going forward.
AMG has been one of the most active investors in independent asset managers over the past 24 months.
Adjusted EBITDA of $357 million grew 40% year over year and economic earnings per share totaled $6.10, up 45% year over year.
On a full year basis, adjusted EBITDA of $1.06 billion and economic earnings per share of $18.28 each grew more than 30% versus the prior year.
Net client cash flows, excluding certain quantitative strategies, were $4 billion for the quarter.
Outflows from certain quant strategies totaled $10 billion and continue to have a de minimis impact on our earnings.
Over the course of 2021, our core organic growth trends gained momentum quarter by quarter, delivering $14 billion in total inflows ex quant for the year.
In alternatives, net inflows totaled $12 billion, driven by strength across private markets and liquid alternatives, and reflected the continuing impact of our strategy to evolve our business toward growth.
In private markets, we continue to see very strong fundraising levels across Baring Asia, Pantheon, EIG, and Comvest, with net inflows totaling $9 billion for the quarter and nearly $25 billion for the full year.
Net outflows of $8 billion were driven by two large institutional redemptions, which accounted for two-thirds of the activity in this category.
Within U.S. equities, we reported net outflows of $1 billion, reflecting Q4 seasonality.
And our long-term investment performance remains excellent, with approximately 75% of assets outperforming on a 5-year basis.
And lastly, in multi-asset and fixed income, we generated inflows of $1.5 billion for the quarter and $4 billion for the full year, with a continuation of steady growth in our wealth management businesses.
For the fourth quarter, adjusted EBITDA of $357 million grew 40% year over year, driven by strong affiliate performance and the addition of our recent new affiliate investments.
Economic earnings per share of $6.10 grew 45% year over year, further benefiting from share repurchases.
We generated $122 million of net performance fees in the fourth quarter, driven by excellent investment performance, most notably in our liquid alternatives category.
Historically, performance fees have proven consistent and durable, averaging approximately 10% of annual earnings, with significant upside asymmetry to those levels in certain years, similar to what we experienced in 2021.
We expect adjusted EBITDA to be in the range of $235 million to $245 million based on current AUM levels, which reflect our market blend, down approximately 4% through Friday.
This guidance reflects performance fees of up to $10 million and the full impact of our recent investments in Abacus and Systematica.
Our share of interest expense was $29 million for the fourth quarter, and we expect a similar level in the first quarter.
Controlling interest depreciation was $2 million in the fourth quarter, and we expect the first quarter to be at a similar level.
Our share of reported amortization and impairments was $88 million for the fourth quarter.
We expect it to be approximately $30 million in the first quarter.
Our effective GAAP and cash tax rates were 30% for the fourth quarter.
And we expect GAAP and cash tax rates to be 26% and 18%, respectively, in the first quarter.
Intangible-related deferred taxes were $1 million this quarter, and we are expecting $15 million in the first quarter.
Other economic item adjustments were negative $12 million for the fourth, reflecting the exclusion of mark-to-market gains.
In the first quarter, for modeling purposes, we expect other economic items, excluding any mark-to-market, to be $1 million.
Our adjusted weighted average share count for the fourth quarter was 41.8 million, and we expect our share count to be approximately 41 million for the first quarter.
And we deployed more than $1 billion of capital into growth investments as well as share repurchases.
These investments were structured and priced to deliver strong shareholder returns across a range of outcomes and are expected to collectively contribute approximately $120 million of EBITDA in 2022.
For the full year, we also repurchased $510 million of shares, including $120 million in the fourth quarter, reducing our shares outstanding by 8% for the year.
And in 2022, we expect to repurchase approximately $400 million of shares, subject to market conditions and new investment activity.
In addition, we took advantage of last year's favorable financing environment to extend the duration of our balance sheet by issuing a 40-year hybrid note and extending our revolver and term loan through 2026.
